2024-04-29 09:24 | CC:TTI | Thiogenesis Therapeutics Corp | 0.75 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2024-04-29 09:24 | CC:TTI | Thiogenesis Therapeutics Corp | 0.75 | SEDAR MD & A815 | SEDAR MD & A |
2024-03-25 12:28 | CC:TTI | Thiogenesis Therapeutics Corp | 0.75 | News Release200 | Thiogenesis CTA accepted by EMA for MELAS trial |
2023-12-29 12:54 | CC:TTI | Thiogenesis Therapeutics Corp | 0.75 | Private Placement250 | Thiogenesis 6,001,167-share private placement |
2023-12-20 12:13 | CC:TTI | Thiogenesis Therapeutics Corp | 0.73 | News Release200 | Thiogenesis closes $312,750 final tranche of financing |
2023-12-18 12:53 | CC:TTI | Thiogenesis Therapeutics Corp | 0.74 | News Release200 | Thiogenesis closes $4.18-million private placement |
2023-11-27 13:35 | CC:TTI | Thiogenesis Therapeutics Corp | 0.80 | News Release200 | Thiogenesis appoints Stanton as scientific adviser |
2023-11-20 13:44 | CC:TTI | Thiogenesis Therapeutics Corp | 0.82 | News Release200 | Thiogenesis arranges $4.5-million private placement |
2023-11-17 12:43 | CC:TTI | Thiogenesis Therapeutics Corp | 0.82 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-11-17 12:41 | CC:TTI | Thiogenesis Therapeutics Corp | 0.82 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-08-24 09:15 | CC:TTI | Thiogenesis Therapeutics Corp | 0.65 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-08-24 09:15 | CC:TTI | Thiogenesis Therapeutics Corp | 0.65 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-05-24 11:35 | CC:TTI | Thiogenesis Therapeutics Corp | 0.78 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-05-24 11:35 | CC:TTI | Thiogenesis Therapeutics Corp | 0.78 | SEDAR MD & A815 | SEDAR MD & A |